Literature DB >> 12538418

Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure.

Justin A Ezekowitz1, Finlay A McAlister, Paul W Armstrong.   

Abstract

BACKGROUND: Although previous work has suggested that anemia is associated with an increased mortality in selected patients with congestive heart failure (CHF), little is known about the prevalence and predictors of anemia, or whether anemia is an independent prognostic factor in unselected, community-based patients with CHF. METHODS AND
RESULTS: We analyzed a population-based cohort of patients with new-onset CHF from a database of patients discharged from 138 acute-care hospitals in Alberta, Canada, between April 1993 and March 2001. Logistic regression, Kaplan-Meier survival analyses, and Cox proportional hazards model were used. Among the 12 065 patients with CHF (median age 78 years), 17% had anemia, 58% of whom had anemia of chronic disease. After adjustment for clinical and demographic variables, patients with anemia were more likely to be older (odds ratio [OR] 1.01 per year) and female (OR 1.2 [95% confidence interval 1.1 to 1.3]) and to have a history of chronic renal insufficiency (OR=3.2 [95% confidence interval 2.8 to 3.6]), or hypertension (OR 1.3 [95% confidence interval 1.2 to 1.5]). Hazard ratios for mortality, adjusting for covariates, were 1.34 (1.24 to 1.46) in anemic patients, and 1.36 (1.23 to 1.50) in those patients with anemia of chronic disease.
CONCLUSIONS: In this large cohort of community-dwelling patients with CHF, anemia is common and an independent prognostic factor for mortality. Further research into the mechanisms of anemia in CHF and randomized controlled trials to test whether correction of anemia improves prognosis in CHF are needed.

Entities:  

Mesh:

Year:  2003        PMID: 12538418     DOI: 10.1161/01.cir.0000052622.51963.fc

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  158 in total

1.  Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction.

Authors:  Sameer Ather; Wenyaw Chan; Biykem Bozkurt; David Aguilar; Kumudha Ramasubbu; Amit A Zachariah; Xander H T Wehrens; Anita Deswal
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

Review 2.  Glutamate synthase: a fascinating pathway from L-glutamine to L-glutamate.

Authors:  R H H van den Heuvel; B Curti; M A Vanoni; A Mattevi
Journal:  Cell Mol Life Sci       Date:  2004-03       Impact factor: 9.261

Review 3.  Anemia and diabetic nephropathy.

Authors:  Eberhard Ritz
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

4.  Clinical outcomes with use of erythropoiesis stimulating agents in patients with the HeartMate II left ventricular assist device.

Authors:  Michael E Nassif; Jayendrakumar S Patel; Jerrica E Shuster; David S Raymer; Ronald Jackups; Eric Novak; Brian F Gage; Sunil Prasad; Scott C Silvestry; Gregory A Ewald; Shane J LaRue
Journal:  JACC Heart Fail       Date:  2015-02       Impact factor: 12.035

5.  Glucose and haemoglobin in the assessment of prognosis after first hospitalisation for heart failure.

Authors:  J D Newton; I B Squire
Journal:  Heart       Date:  2006-04-18       Impact factor: 5.994

6.  Anemia during and at discharge from intensive care: the impact of restrictive blood transfusion practice.

Authors:  Timothy S Walsh; Robert J Lee; Caroline R Maciver; Magnus Garrioch; Fiona Mackirdy; Alexander R Binning; Stephen Cole; D Brian McClelland
Journal:  Intensive Care Med       Date:  2005-11-23       Impact factor: 17.440

7.  Temporal variations in hematocrit values in patients with left ventricular dysfunction: Relationship with cause-specific mortality and morbidity and optimal monitoring--further insights from SOLVD.

Authors:  Simon de Denus; Jean-Claude Tardif; Michel White; Martial G Bourassa; Normand Racine; Sylvie Levesque; Anique Ducharme
Journal:  Can J Cardiol       Date:  2008-01       Impact factor: 5.223

Review 8.  [Percutaneous aortic valve replacement - pro].

Authors:  Lutz Buellesfeld; Eberhard Grube
Journal:  Herz       Date:  2009-03       Impact factor: 1.443

9.  Association between left ventricular dysfunction, anemia, and chronic renal failure. Analysis of the Heart Failure Prevalence and Predictors in Turkey (HAPPY) cohort.

Authors:  A Kepez; B Mutlu; M Degertekin; C Erol
Journal:  Herz       Date:  2013-11-13       Impact factor: 1.443

Review 10.  Cardiorenal syndrome: pathophysiology and potential targets for clinical management.

Authors:  Parta Hatamizadeh; Gregg C Fonarow; Matthew J Budoff; Sirous Darabian; Csaba P Kovesdy; Kamyar Kalantar-Zadeh
Journal:  Nat Rev Nephrol       Date:  2012-12-18       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.